Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Estimated reading time for CME/CPD: 1 min

Psychiatry RAISR4D

Magnitude of Response in Treatment and Control Groups within Psychedelic Trials for Psychiatric Disorders: A Meta-Analysis

Eur Psychiatry. 2026 Feb 18:1-35. doi: 10.1192/j.eurpsy.2026.10168. Online ahead of print.

NO ABSTRACT

PMID:41705428 | DOI:10.1192/j.eurpsy.2026.10168

Document this CPD

Share Evidence Blueprint

QR Code

Search Google Scholar

⭐ My Revision List

RAISR4D-PFD Evidence Matrix

InPsychiatry, RAISR4D

Latest Evidence

Recent Post

Bearing the weight: A phenomenological study of burnout and stress among medicolegal death investigators

Loneliness, not isolation, is the missing link between social connectedness and mental health among midlife to older U.S. adults

Genotype-Phenotype Correlation in Dominant Optic Atrophy due to OPA1 c.3011T>C (p.Leu1004Pro): A Family-Based Case Series

Differential signal strength of male sexual dysfunction associated with antidepressants: a disproportionality analysis of FAERS database

Development and external validation of the SCORE2 models in Latin America and the Caribbean (SCORE2-LAC) to estimate 10-year cardiovascular disease risk

Top Category

ChatGPT

Enter your request.

← Magnitude of Response in Treatment and Control Groups within Psychedelic Trials for Psychiatric Disorders: A Meta-Analysis ← Cannabis dispensary exposure and smoked, vaped and edible cannabis use among young adults: Comparison of web-scraped and government-maintained registries

← →

RAISR4D CME/CPD Evidence Nodes

Swipe to navigate RAISR4D CME/CPD evidence nodes.

CME/CPD